Record Display for the EPA National Library Catalog


Main Title Follow-up of patients receiving diagnostic doses of 131 iodine during childhood /
Author Harris, Benjamin S. H.
Other Authors
Author Title of a Work
Smith, Martha L.
Holt, Mildred I.
Nelson, William C.
CORP Author Research Triangle Inst., Research Triangle Park, NC.;Health Effects Research Lab., Research Triangle Park, NC.
Publisher Health Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency,
Year Published 1978
Report Number EPA-600/1-78-059; EPA-68-02-1213
Stock Number PB 288 439
OCLC Number 37664839
Subjects Iodine--Isotopes--Physiological effect ; Thyroid gland--Cancer--Etiology ; Iodine Isotopes--adverse effects ; Thyroid Neoplasms--etiology
Additional Subjects Iodine 131 ; Isotopes ; Dosage ; Children ; Patients ; Iodine isotopes ; Surveys ; Data collection ; Methodology ; Procedures ; Estimates ; Neoplasms ; Medical records ; Objectives ; Hospitals ; Data processing ; Implementation ; Diagnostic agents ; Thyroid function tests ; Dose response relationships ; Follow up studies
Internet Access
Description Access URL
Library Call Number Additional Info Location Last
EJBD  EPA 600-1-78-059 Headquarters Library/Washington,DC 04/22/2014
ELBD ARCHIVE EPA 600-1-78-059 Received from HQ AWBERC Library/Cincinnati,OH 10/04/2023
ELBD RPS EPA 600-1-78-059 repository copy AWBERC Library/Cincinnati,OH 10/17/2014
NTIS  PB-288 439 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation x, 47 p. ; 29 cm.
The report documents the data collection methodology and procedures of a follow-up survey conducted of persons under 16 years old who received diagnostic Iodine 131 for evaluation of thyroid function at nine clinical centers prior to December 31, 1960. The intent of this data collection effort is to estimate the dose response curve for the development of thyroid neoplasms in young adults who received low diagnostic doses of Iodine 131 as children. Of 2,287 potential study subjects identified, some medical records were reviewed and abstracted for 1,999 or some 87 percent. With study activities incomplete, of 186 private physicians and other referral sources contacted for supplemental data, only three or less than two percent declined to participate; of 1,362 patients who were determined eligible and entered the survey phase, some final resolution (completed questionnaire, death certificate, or refusal) was obtained for 1,065 or some 78 percent. The statistical analysis of these data will be performed under a related project sponsored by the U.S. Food and Drug Administration.